MYD88 and Obesity: Perhaps not surprisingly given this complexity, our hypothesis that ES-62 might counter HCD-accelerated ageing by virtue of its potential to suppress the chronic MyD88-driven inflammation promoting metabolic deregulation, obesity and ageing, per se proved to be rather simplistic.